Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.

Alkam Y, Mitomi H, Nakai K, Himuro T, Saito T, Takahashi M, Arakawa A, Yao T, Saito M.

Histopathology. 2013 Nov;63(5):713-25. doi: 10.1111/his.12220. Epub 2013 Sep 5.

PMID:
24004112
2.

Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.

Su Y, Yin L, Liu R, Sheng J, Yang M, Wang Y, Pan E, Guo W, Pu Y, Zhang J, Liang G.

Med Oncol. 2014 Feb;31(2):784. doi: 10.1007/s12032-013-0784-4. Epub 2013 Dec 24.

PMID:
24366688
3.

Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.

Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH.

Langenbecks Arch Surg. 2011 Oct;396(7):1017-26. doi: 10.1007/s00423-011-0812-9. Epub 2011 Jun 25.

PMID:
21706233
4.

Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.

Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM.

Dig Dis Sci. 2011 Oct;56(10):2992-3004. doi: 10.1007/s10620-011-1774-z. Epub 2011 Jun 15.

PMID:
21674174
5.

Predictive value of MGMT, hMLH1, hMSH2 and BRCA1 protein expression for pathological complete response to neoadjuvant chemotherapy in basal-like breast cancer patients.

Nakai K, Mitomi H, Alkam Y, Arakawa A, Yao T, Tokuda E, Saito M, Kasumi F.

Cancer Chemother Pharmacol. 2012 Apr;69(4):923-30. doi: 10.1007/s00280-011-1777-7. Epub 2011 Nov 15.

PMID:
22083523
6.
7.

Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.

Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.

Life Sci. 2010 Jul 17;87(3-4):83-91. doi: 10.1016/j.lfs.2010.05.001. Epub 2010 May 12.

PMID:
20470789
8.

Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.

Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR.

Clin Cancer Res. 2008 May 1;14(9):2560-9. doi: 10.1158/1078-0432.CCR-07-1802.

9.
10.

Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma.

Michailidi C, Theocharis S, Tsourouflis G, Pletsa V, Kouraklis G, Patsouris E, Papavassiliou AG, Troungos C.

Exp Biol Med (Maywood). 2015 Dec;240(12):1599-605. doi: 10.1177/1535370215583800. Epub 2015 Apr 23.

11.

Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma.

Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D.

Oral Dis. 2009 Apr;15(3):206-13. doi: 10.1111/j.1601-0825.2008.01510.x. Epub 2009 Jan 16.

PMID:
19207881
12.

Correlation of chromosome damage and promoter methylation status of the DNA repair genes MGMT and hMLH1 in Chinese vinyl chloride monomer (VCM)-exposed workers.

Wu F, Liu J, Qiu YL, Wang W, Zhu SM, Sun P, Miao WB, Li YL, Brandt-Rauf PW, Xia ZL.

Int J Occup Med Environ Health. 2013 Mar;26(1):173-82. doi: 10.2478/S13382-013-0079-1. Epub 2013 Feb 15.

13.

Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.

Saetta AA, Aroni K, Stamatelli A, Lazaris AC, Patsouris E.

Arch Dermatol Res. 2005 Sep;297(3):99-107. Epub 2005 Sep 29.

PMID:
16012876
14.

Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.

Li Z, Zhang H, Yang J, Hao T, Li S.

Cell Biol Int. 2012 May 1;36(5):427-32. doi: 10.1042/CBI20100851.

PMID:
21864295
15.

Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.

Li M, Zhao ZW.

Med Oncol. 2012 Jun;29(2):970-6. doi: 10.1007/s12032-011-9968-y. Epub 2011 Jun 10.

PMID:
21660619
16.

Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.

Psofaki V, Kalogera C, Tzambouras N, Stephanou D, Tsianos E, Seferiadis K, Kolios G.

World J Gastroenterol. 2010 Jul 28;16(28):3553-60.

17.

Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.

Fumagalli C, Pruneri G, Possanzini P, Manzotti M, Barile M, Feroce I, Colleoni M, Bonanni B, Maisonneuve P, Radice P, Viale G, Barberis M.

Breast Cancer Res Treat. 2012 Jul;134(1):131-7. doi: 10.1007/s10549-011-1945-9. Epub 2012 Jan 8.

PMID:
22228432
18.

Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.

Tzao C, Hsu HS, Sun GH, Lai HL, Wang YC, Tung HJ, Yu CP, Cheng YL, Lee SC.

J Thorac Cardiovasc Surg. 2005 Nov;130(5):1371. Epub 2005 Oct 13. Erratum in: J Thorac Cardiovasc Surg. 2013 Jul;146(1):245. Lai, Hsiou-Lei [corrected to Lai, Hsiao-Lei].

19.

Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters.

Menigatti M, Truninger K, Gebbers JO, Marbet U, Marra G, Schär P.

Oncogene. 2009 Feb 12;28(6):899-909. doi: 10.1038/onc.2008.444. Epub 2008 Dec 8.

PMID:
19060925
20.

Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.

Stark AM, Doukas A, Hugo HH, Hedderich J, Hattermann K, Maximilian Mehdorn H, Held-Feindt J.

Neurol Res. 2015 Feb;37(2):95-105. doi: 10.1179/1743132814Y.0000000409. Epub 2014 Jul 4.

PMID:
24995467

Supplemental Content

Support Center